Literature DB >> 32265558

IGF-1R drugs travel from cancer cradle to Graves'.

Elie Dolgin1.   

Abstract

Entities:  

Year:  2020        PMID： 32265558     DOI： 10.1038/s41587-020-0481-8

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  5 in total

1.  Treating Thyroid Associated Ophthalmopathy in Pediatric Patients.

Authors:  Tianyu Dong; Zhujun Fu; Xu Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

Review 2.  Emerging Importance of Tyrosine Kinase Inhibitors against Cancer: Quo Vadis to Cure?

Authors:  Raj Kumar Mongre; Chandra Bhushan Mishra; Arvind Kumar Shukla; Amresh Prakash; Samil Jung; Md Ashraf-Uz-Zaman; Myeong-Sok Lee
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

3.  Targeted siRNA nanocarrier: a platform technology for cancer treatment.

Authors:  Nicole Bäumer; Jessica Tiemann; Annika Scheller; Theresa Meyer; Lisa Wittmann; Matias Ezequiel Gutierrez Suburu; Lilo Greune; Matthias Peipp; Neele Kellmann; Annika Gumnior; Caroline Brand; Wolfgang Hartmann; Claudia Rossig; Carsten Müller-Tidow; Dario Neri; Cristian A Strassert; Christian Rüter; Petra Dersch; Georg Lenz; H Phillip Koeffler; Wolfgang E Berdel; Sebastian Bäumer
Journal:  Oncogene       Date:  2022-02-26       Impact factor: 9.867

4.  PINCH-1 promotes IGF-1 receptor expression and skin cancer progression through inhibition of the GRB10-NEDD4 complex.

Authors:  Xiaoxiao Wang; Rong Wang; Kun Jiang; Maohua Zhu; Ling Guo; Chuanyue Wu
Journal:  Theranostics       Date:  2022-02-28       Impact factor: 11.600

5.  Prenatal correction of IGF2 to rescue the growth phenotypes in mouse models of Beckwith-Wiedemann and Silver-Russell syndromes.

Authors:  Ji Liao; Tie-Bo Zeng; Nicholas Pierce; Diana A Tran; Purnima Singh; Jeffrey R Mann; Piroska E Szabó
Journal:  Cell Rep       Date:  2021-02-09       Impact factor: 9.423
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.